| MeSH term | MeSH ID | Detail |
|---|---|---|
| Bronchiolitis | D001988 | 6 associated lipids |
| Boutonneuse Fever | D001907 | 5 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Blister | D001768 | 16 associated lipids |
| Bites, Human | D001734 | 2 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Bartonella Infections | D001474 | 3 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Arthritis, Infectious | D001170 | 8 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Odenholt-Tornqvist I et al. | Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. | 1995 | Antimicrob. Agents Chemother. | pmid:7695310 |
| Malinverni R et al. | Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. | 1995 | Antimicrob. Agents Chemother. | pmid:7695327 |
| Hunter RP et al. | Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. | 1995 | J. Vet. Pharmacol. Ther. | pmid:7752305 |
| Ives DV et al. | Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. | 1995 | AIDS | pmid:7755914 |
| Onyeji CO et al. | Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. | 1995 | J. Infect. Dis. | pmid:7658075 |
| Principi N | Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. | 1995 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8565983 |
| Gill CJ et al. | In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin. | 1995 | J. Antibiot. | pmid:7490222 |
| Spangler SK et al. | Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies. | 1995 | J. Clin. Microbiol. | pmid:7615756 |
| Ramadan MA et al. | Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. | 1995 | J. Med. Microbiol. | pmid:7752216 |
| Lo KK et al. | An open non-comparative pilot study with azithromycin in the treatment of non-gonococcal urethritis in the sexually transmitted disease clinics in Hong Kong. | 1995 | Ann. Acad. Med. Singap. | pmid:8849186 |
| Tissi L et al. | In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. | 1995 | Antimicrob. Agents Chemother. | pmid:8540695 |
| Bergogne-Bérézin E | [Azithromycin: tissue pharmacology]. | 1995 | Pathol. Biol. | pmid:8539071 |
| Singlas E | [Clinical pharmacokinetics of azithromycin]. | 1995 | Pathol. Biol. | pmid:8539072 |
| Felstead S | Azithromycin drug interactions. | 1995 | Pathol. Biol. | pmid:8539073 |
| Modaï J | [Azithromycin: clinical assessment]. | 1995 | Pathol. Biol. | pmid:8539076 |
| Gehanno P | [Use of azithromycin in ORL]. | 1995 | Pathol. Biol. | pmid:8539077 |
| Leophonte P | [Azithromycin and bronchopulmonary infections]. | 1995 | Pathol. Biol. | pmid:8539078 |
| Micoud M and Pépin LF | [Azithromycin and genital infections]. | 1995 | Pathol. Biol. | pmid:8539079 |
| Coulaud JP | [Azithromycin: new orientations]. | 1995 | Pathol. Biol. | pmid:8539080 |
| Reinert P | [Effects of azithromycin on the virulence of Pseudomonas aeruginosa]. | 1995 | Pathol. Biol. | pmid:8539081 |
| Mégraud F et al. | [Helicobacter pylori and azithromycin]. | 1995 | Pathol. Biol. | pmid:8539082 |
| Derouin F | [New pathogens and mode of action of azithromycin: Toxoplasma gondii]. | 1995 | Pathol. Biol. | pmid:8539083 |
| Perronne C | [Azithromycin and Mycobacterium avium infection]. | 1995 | Pathol. Biol. | pmid:8539084 |
| Edelstein PH | Review of azithromycin activity against Legionella spp. | 1995 | Pathol. Biol. | pmid:8539085 |
| Oh YK et al. | Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. | 1995 | Antimicrob. Agents Chemother. | pmid:8540724 |
| Clancy J et al. | Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. | 1995 | J. Antibiot. | pmid:8557568 |
| Amsden GW | Macrolides versus azalides: a drug interaction update. | 1995 | Ann Pharmacother | pmid:8547740 |
| Kuschner RA et al. | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. | 1995 | Clin. Infect. Dis. | pmid:8527539 |
| Wahlstrom E et al. | Improvement in cyclosporine-associated gingival hyperplasia with azithromycin therapy. | 1995 | N. Engl. J. Med. | pmid:7854392 |
| Nahata MC et al. | Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. | 1995 | Antimicrob. Agents Chemother. | pmid:7486938 |
| Tomazic J et al. | Ex vivo effect of azithromycin in human leukocyte bactericidal functions. | 1995 | Antimicrob. Agents Chemother. | pmid:7486947 |
| Zuckerman JM and Kaye KM | The newer macrolides. Azithromycin and clarithromycin. | 1995 | Infect. Dis. Clin. North Am. | pmid:7490441 |
| Kobayashi H et al. | [Study on azithromycin in treatment of diffuse panbronchiolitis]. | 1995 | Kansenshogaku Zasshi | pmid:7616016 |
| Ljutić D and Rumboldt Z | Possible interaction between azithromycin and cyclosporin: a case report. | 1995 | Nephron | pmid:7617103 |
| Nilsen OG | Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin. | 1995 | Infection | pmid:7782117 |
| Anderson SL et al. | Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. | 1995 | Ann. Intern. Med. | pmid:7574195 |
| Backman JT et al. | Azithromycin does not increase plasma concentrations of oral midazolam. | 1995 | Int J Clin Pharmacol Ther | pmid:7582388 |
| Harris S et al. | Azithromycin and terfenadine: lack of drug interaction. | 1995 | Clin. Pharmacol. Ther. | pmid:7554704 |
| Bokemeyer B | [Combined therapy with azithromycin and omeprazole for the eradication of Helicobacter pylori]. | 1995 | Dtsch. Med. Wochenschr. | pmid:7555645 |
| Péc J et al. | [Treatment of chlamydia infections and a brief review of the problems]. | 1995 | Bratisl Lek Listy | pmid:7633932 |
| Bowden FJ et al. | Azithromycin and syphilis. | 1995 | Genitourin Med | pmid:7635501 |
| Yeo AE and Rieckmann KH | Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. | 1995 | Int. J. Parasitol. | pmid:7635629 |
| Bamberger DM et al. | Azithromycin in an experimental Staphylococcus aureus abscess model. | 1995 | J. Antimicrob. Chemother. | pmid:7592175 |
| Adegbola RA et al. | Effect of azithromycin on pharyngeal microflora. | 1995 | Pediatr. Infect. Dis. J. | pmid:7603826 |
| Vartiovaara I | Living with Lyme. | 1995 | Lancet | pmid:7605437 |
| Pascual A et al. | Factors affecting the intracellular accumulation and activity of azithromycin. | 1995 | J. Antimicrob. Chemother. | pmid:7768786 |
| Beghi G et al. | Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. | 1995 | J Chemother | pmid:7666122 |
| [New ways of antibiotic therapy]. | 1995 | Internist (Berl) | pmid:9431354 | |
| Van Asselt GJ et al. | Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro. | 1995 | J. Med. Microbiol. | pmid:7563004 |
| Bessette RE and Amsden GW | Treatment of non-HIV cryptosporidial diarrhea with azithromycin. | 1995 | Ann Pharmacother | pmid:8845560 |